Evidence map›Paper›PMID 23840099›Full record

ArticleMediators of inflammation2013

Nitric oxide is a mediator of antiproliferative effects induced by proinflammatory cytokines on pancreatic beta cells.

Laura Quintana-Lopez, Manuel Blandino-Rosano, Gonzalo Perez-Arana, Alberto Cebada-Aleu, Alfonso Lechuga-Sancho, Manuel Aguilar-Diosdado, Carmen Segundo

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in endocrinology · 2022
    Article
  4. Review
  5. Review
  6. Review
  7. Observational
  8. Survival of encapsulated islets: More than a membrane story.World journal of transplantation · 2016
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Laura Quintana-LopezInvestigation Unit, Puerta del Mar Hospital, Cadiz, Spain.
Manuel Blandino-Rosano
Gonzalo Perez-Arana
Alberto Cebada-Aleu
Alfonso Lechuga-Sancho
Manuel Aguilar-Diosdado
Carmen Segundo
Hospital Universitario Puerta del Mar · ESUniversidad de Cádiz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) is involved in several biological processes. In type 1 diabetes mellitus (T1DM), proinflammatory cytokines activate an inducible isoform of NOS (iNOS) in β cells, thus increasing NO levels and inducing apoptosis. The aim of the current study is to determine the role of NO (1) in the antiproliferative effect of proinflammatory cytokines IL-1 β , IFN- γ , and TNF- α on cultured islet β cells and (2) during the insulitis stage prior to diabetes onset using the Biobreeding (BB) rat strain as T1DM model. Our results indicate that NO donors exert an antiproliferative effect on β cell obtained from cultured pancreatic islets, similar to that induced by proinflammatory cytokines. This cytokine-induced antiproliferative effect can be reversed by L-NMMA, a general NOS inhibitor, and is independent of guanylate cyclase pathway. Assays using NOS isoform specific inhibitors suggest that the NO implicated in the antiproliferative effect of proinflammatory cytokines is produced by inducible NOS, although not in an exclusive way. In BB rats, early treatment with L-NMMA improves the initial stage of insulitis. We conclude that NO is an important mediator of antiproliferative effect induced by proinflammatory cytokines on cultured β cell and is implicated in β -cell proliferation impairment observed early from initial stage of insulitis.

Indexed as

AnimalsBlotting, WesternBody WeightCell ProliferationCytokinesFluorescent Antibody TechniqueGuanylate CyclaseInsulin-Secreting CellsInterferon-gammaInterleukin-1betaMaleNitric OxideNitric Oxide DonorsNitric Oxide Synthaseomega-N-MethylarginineRatsCytokinesGuanylate CyclaseInterferon-gammaInterleukin-1betaNitric OxideNitric Oxide DonorsNitric Oxide Synthaseomega-N-MethylarginineTumor Necrosis Factor-alpha

Identifiers

PMID23840099
PMCPMC3694487
OpenAlexW2162195592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.